Produktname:2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid

IUPAC Name:2-(5-methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid

CAS:261768-25-6
Molekulare Formel:C7H8N2O3
Reinheit:95%
Katalognummer:CM321157
Molekulargewicht:168.15

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM321157-1g in stock ŗůǤNJ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:261768-25-6
Molekulare Formel:C7H8N2O3
Schmelzpunkt:-
SMILES-Code:O=C(O)CC(C=C1C)=NNC1=O
Dichte:
Katalognummer:CM321157
Molekulargewicht:168.15
Siedepunkt:
Mdl-Nr.:MFCD23106035
Lagerung:

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

Product Other Information

Product Overview 2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid (2-MOPAA) is a derivative of the pyridazinone family of compounds. It is a small molecule that has a variety of biological activities and has been studied for its potential in treating a variety of diseases.
Physical Properties It is not very water soluble, which can make it difficult to dissolve and use in experiments.
Chemical Properties It is a small molecule, which makes it easy to synthesize and manipulate in the laboratory. It has been found to have a relatively short half-life, which can make it difficult to study its effects over a prolonged period of time.
Synthesis and Application It has been found to have anti-inflammatory properties and has been studied for its potential to treat inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. It has also been studied for its potential to act as an anti-cancer agent and has been found to have anti-tumor activity in several cancer cell lines. It has also been studied for its potential to act as an anti-oxidant and to modulate the activity of several proteins.
Future Directions These include further studying its anti-inflammatory, anti-cancer, and anti-oxidant properties. Additionally, further studies can be done to explore its potential to act as an enzyme inhibitor and to modulate the activity of several proteins. Additionally, further research can be done to explore the potential of 2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid as an anti-viral agent. Finally, further research can be done to explore the potential of 2-(5-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)acetic acid as a drug delivery agent, as it has been found to have a relatively short half-life.